Walker CJ, Flanagan KE, Pathoulas JT, Pupo Wiss I, Senna MM. Hair Growth in a Patient with Alopecia Areata on Tocilizumab.
Skin Appendage Disord 2021;
7:408-412. [PMID:
34604334 DOI:
10.1159/000516300]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Accepted: 03/27/2021] [Indexed: 11/19/2022] Open
Abstract
Introduction
Tocilizumab (TCZ), a recombinant humanized antihuman monoclonal antibody targeting interleukin-6 (IL-6) signaling, is often utilized in the management of autoimmune disease. Few reports have demonstrated hair growth changes in patients on TCZ.
Case Presentation
Herein, we review the literature and report a 21-year-old woman with progressive alopecia areata (AA) presenting with AA improvement while on TCZ for concomitant posterior uveitis.
Discussion
Our case demonstrates the potential ability of TCZ to disrupt IL-6 signaling involved in AA, leading to hair loss and regrowth.
Collapse